Abstract
Botulinum neurotoxin serotypes A, B and E were modified at pH 7.9 with tetranitromethane, a reagent highly specific for tyrosine residues. The type B and E neurotoxins were completely detoxified without significant damage to their serological activities. Under similar modification conditions, the type A neurotoxin was incompletely detoxified with some alteration in its serological reactivity. Modification of only tyrosine residues to nitrotyrosine was evident from amino acid analysis of the acid hydrolysates of the modified proteins. The completely detoxified type B and E neurotoxins, used as toxoid, elicited antibodies in rabbits. The antisera precipitated and neutralized the homologous neurotoxin. The two toxoids, type B and E, were prepared with >99% pure neurotoxins as tested by sodium dodecyl sulfate-polyacrylamide gel electrophoresis whereas the traditional toxoids produced with formaldehyde are very crude preparations of the neurotoxin (∼ 90% impure). Chemical modification using tetranitromethane is more specific than products that form during ∼ 7 days of reaction between a protein and formaldehyde. The toxoids produced with tetranitromethane may be considered second-generation toxoids, compared with the first-generation toxoids (crude preparation of neurotoxins detoxified with formaldehyde).
Similar content being viewed by others
References
Sugiyama H:Clostridium botulinum neurotoxin. Microbiol Rev 44:419–448, 1980
Sakaguchi G:Clostridium botulinum toxins. Pharmacol Ther 19:165–194, 1983
Simpson LL: The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 33:155–188, 1981
Cardella MA: Botulinum toxoids. In: KH Lewis and K Cassel Jr (eds) Botulism, Proceedings of a Symposium, U.S. Public Health Service Publication #999-FP-1, Public Health Service, Cincinnati, Ohio, 1964, pp 113–130
Bowmer EJ: Preparation and assay of the international standards forClostridium botulinum types A, B, C, D and E antitoxins. Bull Wld Hlth Org 29:701–709, 1963
DasGupta BR, Rasmussen S: Effect of diethylpyrocarbonate on the biological activities of botulinum neurotoxin types A and E. Arch Biochem Biophys 232:172–178, 1984
Riordan JF, Vallee JF: Nitration with tetranitromethane. Meth Enzymol 25:515–521, 1972
DasGupta BR, Sathyamoorthy V: Purification and amino acid composition of type A botulinum neurotoxin. Toxicon 22:415–424, 1984
DasGupta BR, Woody M: Amino acid composition ofClostridium botulinum type B neurotoxin. Toxicon 22:312–315, 1984
DasGupta BR, Rasmussen S: Purification and amino acid composition of type E botulinum neurotoxin. Toxicon 21:535–545, 1983
DasGupta BR, Sugiyama H: A common subunit structure inClostridium botulinum type A, B and E toxins. Biochem Biophys Res Commun 48:108–112, 1972
Sathyamoorthy V, DasGupta BR: Separation, purification, partial characterization and comparison of the heavy and light chains of botulinum neurotoxin type A, B and E. J Biol Chem 260:10461–10466, 1985
DasGupta BR: Microbial food toxicants:Clostridium botulinum toxins. In: M Rechcigl Jr (ed) CRC Handbook of Foodborne Diseases of Biological Origin, CRC Press, Boca Raton, 1983, pp 25–55
DasGupta BR, Sugiyama H: Inhibition ofClostridium botulinum types A and B hemagglutinins by sugars. Can J Microbiol 23:1257–1260, 1977
Boroff DA, Fleck U: Statistical analysis of a rapid in vivo method for the titration of the toxin ofClostridium botulinum. J Bacteriol 92:1580–1581, 1966
Sugiyama H, DasGupta BR, Ohishi I: Disulfide-immunogenicity relationship of botulinum toxins. Proc Soc Exptl Biol Med 145:1306–1309, 1974
Kozaki S, Sakaguchi G: Antigenicities of fragments ofClostridium botulinum type B derivative toxin. Infect Immun 11:932–936, 1975
Moore S: The precision and sensitivity of amino acid analysis. In: J Meinhoffer (ed) Chemistry and Biology of Peptides. Ann Arbor Science Publishers Inc., Ann Arbor, MI, 1972, pp 629–653
DasGupta BR, Rasmussen S: Role of amino groups in the structure and biological activity of botulinum neurotoxin types A and E. Biochem Biophys Res Commun 101:1209–1215, 1981
Markland FS, Bacharach ADE, Weber BH, O'Grady TC, Saunders GC, Umemura N: Chemical modification of yeast 3-phosphoglycerate kinase. J Biol Chem 250:1301–1310, 1975
Cuatrecasas P, Fuchs S, Anfinsen CB: The tyrosyl residues at the active site of staphylococcal nuclease, modification by tetranitromethane. J Biol Chem 243:4748–4798, 1968
Gaillard FL, Racadot A, Aubert J-P, Dantrevaux M: Modification of human transcortin by tetranitromethane. Evidence for the implication of a tyrosine residue in cortisol binding. Biochimie 64:153–158, 1982
Williams J: The identification of protected tyrosine residues in iron-ovotransferrin. Biochem J 201:647–651, 1982
Kabat EA, Mayer MM: Experimental Immunochemistry. C. C. Thomas, Springfield, Ill., 2nd ed, 1961
Akama K, Ito A, Yamamoto A, Sadahiro S: Reversion of toxicity of tetanus toxoid. Jap J Med Sci Biol 24:181–182, 1971
Akama K, Kameyama S, Otani S, Sadahiro S, Murata R: Reversion of toxicity of diphtheria toxoid. Jap J Med Sci Biol 24:183–187, 1971
Knox JN, Brown WP, Spero L: The role of sulfhydryl groups in the activity of type A botulinum toxin. Biochim Biophys Acta 214:350–354, 1970
Beers WH, Reich E: Isolation and characterization ofClostridium botulinum type B toxin. J Biol Chem 244:4473–4479, 1969
Boroff DA, DasGupta BR: Study of the toxin ofClostridium botulinum. Effects of 2-hydroxy-5-nitrobenzyl bromide on the biological activity of botulinum toxin. Biochim Biophys Acta 117:289–296, 1966
Shibaeva IV, Kolesnikova VA, Ivanov K: Change in the biological properteis of botulinic neurotoxin type A after chemical modification of the tryptophan and tyrosine residues in its molecule. Biokhimiya 46:825–831, 1981
Singh BR, DasGupta BR: Molecular differences between type A botulinum neurotoxin and its toxoid. Toxicon (in press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Woody, M., DasGupta, B.R. Effect of tetranitromethane on the biological activities of botulinum neurotoxin types A, B and E. Mol Cell Biochem 85, 159–169 (1989). https://doi.org/10.1007/BF00577111
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00577111